ES2121404T3 - Procedimiento para la preparacion de trihidrato del (2r,3s)-3-terc-butoxicarbonilamino-2-hidroxi-3-fenilpropionato de 4-acetoxi-2alfa-benzoiloxi-5beta,20-epoxi-1,7beta,10beta-trihidroxi-9-oxo-tax-11-en-13alfa-ilo. - Google Patents
Procedimiento para la preparacion de trihidrato del (2r,3s)-3-terc-butoxicarbonilamino-2-hidroxi-3-fenilpropionato de 4-acetoxi-2alfa-benzoiloxi-5beta,20-epoxi-1,7beta,10beta-trihidroxi-9-oxo-tax-11-en-13alfa-ilo.Info
- Publication number
- ES2121404T3 ES2121404T3 ES95925022T ES95925022T ES2121404T3 ES 2121404 T3 ES2121404 T3 ES 2121404T3 ES 95925022 T ES95925022 T ES 95925022T ES 95925022 T ES95925022 T ES 95925022T ES 2121404 T3 ES2121404 T3 ES 2121404T3
- Authority
- ES
- Spain
- Prior art keywords
- beta
- tax
- oxo
- preparation
- trihydrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Epoxy Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
PROCEDIMIENTO DE PREPARACION DE TRIHIDRATO DE ( 2R, 3S )}TERT-BUTOXICARBONILAMINO-2-HIDROXI-3-FENILPROPIONATO DE 4ACETOXI-2{AL}-BENCOILOXI-5{BE},20-EPOXI-1,7{BE}-TRIHODROXI-9-OXO-TAX-11-EN-13{AL}-ILO POR CRISTALIZACION A PARTIR DE UNA SOLUCION HIDROALCOHOLICA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9408479A FR2722191B1 (fr) | 1994-07-08 | 1994-07-08 | Procede de preparation du trihydrate du (2r,3s)-3-tertbutoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4-acetoxy2alpha-benzoyloxy-5beta,20epoxy-1,7beta,10beta trihydroxy-9-oxo-tax-11-en-13alpha-yle |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2121404T3 true ES2121404T3 (es) | 1998-11-16 |
Family
ID=9465183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95925022T Expired - Lifetime ES2121404T3 (es) | 1994-07-08 | 1995-07-07 | Procedimiento para la preparacion de trihidrato del (2r,3s)-3-terc-butoxicarbonilamino-2-hidroxi-3-fenilpropionato de 4-acetoxi-2alfa-benzoiloxi-5beta,20-epoxi-1,7beta,10beta-trihidroxi-9-oxo-tax-11-en-13alfa-ilo. |
Country Status (38)
Country | Link |
---|---|
US (1) | US6022985A (es) |
EP (1) | EP0770070B1 (es) |
JP (1) | JP3753155B2 (es) |
KR (1) | KR100391753B1 (es) |
CN (1) | CN1067996C (es) |
AT (1) | ATE171702T1 (es) |
AU (1) | AU706519B2 (es) |
BR (1) | BR9508789A (es) |
CA (1) | CA2193531C (es) |
CO (1) | CO4410189A1 (es) |
CZ (1) | CZ284695B6 (es) |
DE (1) | DE69505128T2 (es) |
DK (1) | DK0770070T3 (es) |
DZ (1) | DZ1905A1 (es) |
ES (1) | ES2121404T3 (es) |
FI (1) | FI119246B (es) |
FR (1) | FR2722191B1 (es) |
GR (1) | GR3027558T3 (es) |
HU (1) | HU220634B1 (es) |
IL (1) | IL114274A (es) |
IN (1) | IN183947B (es) |
IS (1) | IS2032B (es) |
MA (1) | MA23606A1 (es) |
MX (1) | MX9700173A (es) |
MY (1) | MY118481A (es) |
NO (1) | NO314500B1 (es) |
NZ (1) | NZ289455A (es) |
PE (1) | PE8697A1 (es) |
PL (1) | PL179876B1 (es) |
RU (1) | RU2126397C1 (es) |
SI (1) | SI0770070T1 (es) |
SK (1) | SK280520B6 (es) |
TN (1) | TNSN95071A1 (es) |
TW (1) | TW419473B (es) |
UA (1) | UA51624C2 (es) |
UY (1) | UY23991A1 (es) |
WO (1) | WO1996001815A1 (es) |
ZA (1) | ZA955646B (es) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL336523A1 (en) | 1997-04-28 | 2000-07-03 | Rhone Poulenc Rorer Sa | Intraneoplastic delivery of an angiogenesis antagonist by means of adenoviruses in order to treat neoplasms |
SE510650C2 (sv) | 1997-05-30 | 1999-06-14 | Astra Ab | Ny förening |
FR2794771B1 (fr) | 1999-06-11 | 2001-08-10 | Aventis Pharma Sa | Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis) |
US6853921B2 (en) | 1999-07-20 | 2005-02-08 | Halliburton Energy Services, Inc. | System and method for real time reservoir management |
US6266619B1 (en) * | 1999-07-20 | 2001-07-24 | Halliburton Energy Services, Inc. | System and method for real time reservoir management |
GB9920548D0 (en) * | 1999-08-31 | 1999-11-03 | Rhone Poulenc Rorer Sa | Treatment of hepatocellular carcinoma |
US6891050B2 (en) * | 2001-08-10 | 2005-05-10 | Dabur India Limited | Process for the preparation of taxanes such as paclitaxel, docetaxel and structurally similar analogs |
US6881852B2 (en) * | 2002-02-05 | 2005-04-19 | Dabur India Limited | Process of purification of paclitaxel and docetaxel |
US7247738B2 (en) * | 2002-05-07 | 2007-07-24 | Dabur India Limited | Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl) ethoxycarbonyl]-5-oxazolidine carboxylic acids |
US6900342B2 (en) * | 2002-05-10 | 2005-05-31 | Dabur India Limited | Anticancer taxanes such as paclitaxel, docetaxel and their structural analogs, and a method for the preparation thereof |
US6838569B2 (en) * | 2002-12-16 | 2005-01-04 | Dabur India Limited | Process for preparation of paclitaxel trihydrate and docetaxel trihydrate |
US7584165B2 (en) * | 2003-01-30 | 2009-09-01 | Landmark Graphics Corporation | Support apparatus, method and system for real time operations and maintenance |
US8703982B2 (en) * | 2003-03-17 | 2014-04-22 | Phyton Holdings Llc | Purification of taxanes |
CN1268619C (zh) * | 2003-05-08 | 2006-08-09 | 上海迪赛诺化学制药有限公司 | 多烯紫杉醇三水化合物的制备方法 |
EP1947094A3 (en) | 2003-12-12 | 2009-02-18 | Quiral Quimica Do Brasil | Process for the preparation of taxane derivatives |
US7142986B2 (en) * | 2005-02-01 | 2006-11-28 | Smith International, Inc. | System for optimizing drilling in real time |
CN100420681C (zh) * | 2005-04-29 | 2008-09-24 | 上海奥锐特国际贸易有限公司 | 多烯紫杉醇三水物的制备方法 |
PL3311805T3 (pl) | 2005-08-31 | 2020-07-27 | Abraxis Bioscience, Llc | Kompozycje zawierające słabo rozpuszczalne w wodzie środki farmaceutyczne i środki przeciwdrobnoustrojowe |
NZ566705A (en) | 2005-08-31 | 2011-06-30 | Abraxis Bioscience Llc | Compositions and methods for preparation of poorly water soluble drugs with increased stability |
EP1819688A2 (en) * | 2005-10-12 | 2007-08-22 | Sicor, Inc. | Crystalline forms of docetaxel and processes for their preparation |
KR100995390B1 (ko) | 2006-01-02 | 2010-11-19 | 주식회사 삼양제넥스 | 무정형, 무수결정형 또는 수화 결정형 도세탁셀의 제조방법 |
WO2007084611A2 (en) * | 2006-01-20 | 2007-07-26 | Landmark Graphics Corporation | Dynamic production system management |
US20100160653A1 (en) * | 2006-03-21 | 2010-06-24 | Dr. Reddy's Laboratories Ltd. | Docetaxel polymorphs and processes |
JP2010506932A (ja) * | 2006-10-20 | 2010-03-04 | シノファーム シンガポール ピーティーイー,リミテッド | 結晶性の無水ドセタキセルの製造方法 |
KR100868116B1 (ko) | 2007-04-09 | 2008-11-10 | 한미약품 주식회사 | 도세탁셀·모노프로필렌글라이콜 내포화합물 및 이의제조방법 |
KR100878455B1 (ko) * | 2007-04-10 | 2009-01-13 | 한미약품 주식회사 | 안정한 무수결정형 도세탁셀 및 이의 제조방법 |
US20100197944A1 (en) * | 2007-07-04 | 2010-08-05 | Dr. Reddy's Laboratories Limited | Docetaxel process and polymorphs |
ES2389518T3 (es) * | 2008-01-18 | 2012-10-26 | Indena S.P.A. | Formas sólidas de ortataxel |
EP2080763A1 (en) * | 2008-01-18 | 2009-07-22 | INDENA S.p.A. | Crystalline form I of ortataxel |
PL388144A1 (pl) | 2009-05-29 | 2010-12-06 | Przedsiębiorstwo Produkcyjno-Wdrożeniowe Ifotam Spółka Z Ograniczoną Odpowiedzialnością | Solwaty (2R,3S)-3-tert-butoksykarbonylamino-2-hydroksy-3-fenylopropionianu 4-acetoksy-2α-benzoiloksy -5β,20-epoksy-1,7β,10β-trihydroksy-9-okso-taks-11-en-13α-ylu, sposób ich otrzymywania i zastosowanie |
ES2621613T3 (es) | 2009-11-04 | 2017-07-04 | Emcure Pharmaceuticals Limited | Un proceso mejorado para la preparación de derivados de taxano |
US10842770B2 (en) | 2010-05-03 | 2020-11-24 | Teikoku Pharma Usa, Inc. | Non-aqueous taxane pro-emulsion formulations and methods of making and using the same |
WO2012160568A1 (en) * | 2011-05-23 | 2012-11-29 | Shilpa Medicare Limited | Process for preparing docetaxel trihydrate polymorph |
PT2753355T (pt) | 2011-09-08 | 2019-02-01 | Univ New York | Vírus herpes simplex oncolítico e suas utilizações terapêuticas |
US9745631B2 (en) | 2011-12-20 | 2017-08-29 | Dana-Farber Cancer Institute, Inc. | Methods for diagnosing and treating oncogenic kras-associated cancer |
EA031986B1 (ru) | 2012-04-04 | 2019-03-29 | Галозим, Инк. | Способ и комбинация для лечения солидной раковой опухоли и набор, содержащий комбинацию |
EP2855698A4 (en) | 2012-05-24 | 2016-03-30 | Dana Farber Cancer Inst Inc | TARGETING THE PATHWAY FROM GLUTAMINE TO PYRUVATE TO TREAT CANCER ASSOCIATED WITH ONCOGEN KRAS |
US20150285802A1 (en) | 2012-07-18 | 2015-10-08 | Dana-Farber Cancer Institute, Inc. | Methods for treating, preventing and predicting risk of developing breast cancer |
JO3685B1 (ar) | 2012-10-01 | 2020-08-27 | Teikoku Pharma Usa Inc | صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها |
WO2014149871A1 (en) | 2013-03-14 | 2014-09-25 | Icahn School Of Medicine At Mount Sinai | Autologous tumor lysate-loaded dendritic cell vaccine for treatment of liver cancer |
US10130590B2 (en) | 2013-10-01 | 2018-11-20 | Dana-Farber Cancer Institute, Inc. | Methods of treating cancer with atovaquone-related compounds |
WO2015149006A2 (en) | 2014-03-27 | 2015-10-01 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for modulating ncoa4-mediated autophagic targeting of ferritin |
MA39818A (fr) | 2014-03-30 | 2017-02-08 | Benevir Biopharm Inc | Virus oncolytiques « armés » comprenant un inhibiteur de tap exogène et leurs utilisations thérapeutiques |
WO2016205429A1 (en) | 2015-06-15 | 2016-12-22 | New York University | Method of treatment using oncolytic viruses |
US20190351031A1 (en) | 2018-05-16 | 2019-11-21 | Halozyme, Inc. | Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2601675B1 (fr) * | 1986-07-17 | 1988-09-23 | Rhone Poulenc Sante | Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent |
US5229526A (en) * | 1991-09-23 | 1993-07-20 | Florida State University | Metal alkoxides |
-
1994
- 1994-07-08 FR FR9408479A patent/FR2722191B1/fr not_active Expired - Fee Related
-
1995
- 1995-06-22 IL IL11427495A patent/IL114274A/xx not_active IP Right Cessation
- 1995-07-03 UY UY23991A patent/UY23991A1/es not_active IP Right Cessation
- 1995-07-04 DZ DZ950082A patent/DZ1905A1/fr active
- 1995-07-05 PE PE1995272899A patent/PE8697A1/es not_active IP Right Cessation
- 1995-07-05 TN TNTNSN95071A patent/TNSN95071A1/fr unknown
- 1995-07-06 TW TW084106974A patent/TW419473B/zh not_active IP Right Cessation
- 1995-07-06 MY MYPI95001895A patent/MY118481A/en unknown
- 1995-07-06 ZA ZA955646A patent/ZA955646B/xx unknown
- 1995-07-06 IN IN1260DE1995 patent/IN183947B/en unknown
- 1995-07-06 MA MA23945A patent/MA23606A1/fr unknown
- 1995-07-07 SI SI9530138T patent/SI0770070T1/xx unknown
- 1995-07-07 UA UA97010077A patent/UA51624C2/uk unknown
- 1995-07-07 BR BR9508789A patent/BR9508789A/pt not_active Application Discontinuation
- 1995-07-07 CA CA002193531A patent/CA2193531C/fr not_active Expired - Lifetime
- 1995-07-07 AT AT95925022T patent/ATE171702T1/de active
- 1995-07-07 CN CN95193984A patent/CN1067996C/zh not_active Expired - Lifetime
- 1995-07-07 MX MX9700173A patent/MX9700173A/es unknown
- 1995-07-07 US US08/776,333 patent/US6022985A/en not_active Expired - Lifetime
- 1995-07-07 WO PCT/FR1995/000910 patent/WO1996001815A1/fr active IP Right Grant
- 1995-07-07 DK DK95925022T patent/DK0770070T3/da active
- 1995-07-07 CZ CZ9735A patent/CZ284695B6/cs not_active IP Right Cessation
- 1995-07-07 ES ES95925022T patent/ES2121404T3/es not_active Expired - Lifetime
- 1995-07-07 EP EP95925022A patent/EP0770070B1/fr not_active Expired - Lifetime
- 1995-07-07 RU RU97101875A patent/RU2126397C1/ru active
- 1995-07-07 SK SK6-97A patent/SK280520B6/sk not_active IP Right Cessation
- 1995-07-07 NZ NZ289455A patent/NZ289455A/en not_active IP Right Cessation
- 1995-07-07 DE DE69505128T patent/DE69505128T2/de not_active Expired - Lifetime
- 1995-07-07 PL PL95318195A patent/PL179876B1/pl unknown
- 1995-07-07 JP JP50415896A patent/JP3753155B2/ja not_active Expired - Fee Related
- 1995-07-07 AU AU29305/95A patent/AU706519B2/en not_active Expired
- 1995-07-07 CO CO95029779A patent/CO4410189A1/es unknown
- 1995-07-07 KR KR1019970700118A patent/KR100391753B1/ko not_active IP Right Cessation
- 1995-07-07 HU HU9700041A patent/HU220634B1/hu unknown
-
1997
- 1997-01-02 NO NO19970007A patent/NO314500B1/no not_active IP Right Cessation
- 1997-01-07 IS IS4411A patent/IS2032B/is unknown
- 1997-01-07 FI FI970069A patent/FI119246B/fi not_active IP Right Cessation
-
1998
- 1998-01-01 GR GR980400355T patent/GR3027558T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2121404T3 (es) | Procedimiento para la preparacion de trihidrato del (2r,3s)-3-terc-butoxicarbonilamino-2-hidroxi-3-fenilpropionato de 4-acetoxi-2alfa-benzoiloxi-5beta,20-epoxi-1,7beta,10beta-trihidroxi-9-oxo-tax-11-en-13alfa-ilo. | |
ES2128412T3 (es) | Un producto que contiene dioxido de silicio y un metodo para su preparacion. | |
DK0882154T3 (da) | Sammensætning af blødgørende lotion, dens anvendelse til papirfremstilling og opnået papirprodukt | |
BR0009340B1 (pt) | composiÇço adequada para uso na pele ou no cabelo, produto para aplicaÇço na pele ou no cabelo, mÉtodo para preparar uma composiÇço adequada para aplicaÇço na pele ou no cabelo, e, uso de uma composiÇço. | |
FR2722410B1 (fr) | Procede de stabilisation des acides gras poly-insatures et utilisation de ces produits stabilises entherapeutique | |
CO4700286A1 (es) | PROCEDIMIENTO DE PREPARACION DEL TRIHIDRATO DEL (2R,3S)-3- BENZOILAMINO-2-HIDROXI-3-FENILPROPIONATO DE 4,10-DIACETOXI- 2(alfa)-BENZOILOXI-5(beta),20-EPOXI-1,7(beta)-DIHIDROXI-9- OXO-TAX-11-EN 13(beta)-ILO | |
DK1021433T3 (da) | Fremgangsmåde til fremstilling af naturlige 1,3-diolderivater og tilsvarende naturlige 1,3-dioxanderivater | |
ES2120055T3 (es) | Procedimiento para la obtencion biotecnologica de alcoholes, aldehidos y acidos carboxilicos. | |
ES491047A0 (es) | Procedimiento para la obtencion de 4,6-dioxa-5-alquil-trici-clo(7.2.1.0 2,8)-dodec-10-enos, de efecto aromatizante | |
ES402066A1 (es) | Un metodo para preparar una composicion topica para aplicara piel animal y humana. | |
PL310207A1 (en) | Nisatidin containing pharmaceutical agent, method of obtaining nisatidin in its specific form and specific form of nisatidin as such | |
SU1791978A1 (ru) | Кормовая добавка | |
FR2601386B1 (fr) | Procede de bioconversion selective du dinitrate d'isosorbitol | |
ES257236U (es) | Cama anatomica | |
HUT55735A (en) | Process for producing new plant cultiviting medium by using mainly natural waste materials | |
TH7817S (th) | ภาชนะสำหรับใส่อุปกรณ์ทำให้อากาศสดชื่น | |
TH2755S1 (th) | ภาชนะสำหรับใส่อุปกรณ์ทำให้อากาศสดชื่น | |
JPS54144319A (en) | Novel aminoglucopyranoside derivative its preparation, and oncostatic drugs comprising it as active constituent | |
ES2094817T3 (es) | Procedimiento para la racemizacion de acidos 3-oxo-ciclopentano- o 3-oxo-ciclohexano-carboxilicos no racemicos, o de sus esteres con alcoholes c1-c6. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 770070 Country of ref document: ES |